
|Videos|April 9, 2021
Treatment considerations in node-positive prostate cancer
Author(s)Urology Times staff
Jason Zhu, MD, discusses factors he considers when choosing treatment for patients with lymph node–positive prostate cancer after prostatectomy.
Advertisement
Jason Zhu, MD, a medical oncologist at Levine Cancer Institute, part of Atrium Health, discusses factors he considers when choosing treatment for patients with lymph node–positive prostate cancer after prostatectomy.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA provides guidance on development pathway for testosterone therapy for women
2
Pearls & Perspectives: Leadership and Prostate Cancer, with Mark L. Gonzalgo, MD, PhD, MBA
3
Pedro Freitas, MD, on consolidative surgery vs prolonged systemic therapy in MIBC
4
Treatment Selection in Advanced Prostate Cancer
5






